Progress in Shigella vaccine development

被引:0
|
作者
Kotloff, KL [1 ]
机构
[1] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:130 / 139
页数:10
相关论文
共 50 条
  • [1] Recent progress towards development of a Shigella vaccine
    Isabel Camacho, Ana
    Manuel Irache, Juan
    Gamazo, Carlos
    EXPERT REVIEW OF VACCINES, 2013, 12 (01) : 43 - 55
  • [2] Progress and pitfalls in Shigella vaccine research
    Eileen M. Barry
    Marcela F. Pasetti
    Marcelo B. Sztein
    Alessio Fasano
    Karen L. Kotloff
    Myron M. Levine
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 245 - 255
  • [3] Progress and pitfalls in Shigella vaccine research
    Barry, Eileen M.
    Pasetti, Marcela F.
    Sztein, Marcelo B.
    Fasano, Alessio
    Kotloff, Karen L.
    Levine, Myron M.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (04) : 245 - 255
  • [4] Frontiers in Shigella Vaccine Development
    MacLennan, Calman Alexander
    Steele, Andrew Duncan
    VACCINES, 2022, 10 (09)
  • [5] Status of vaccine research and development for Shigella
    Mani, Sachin
    Wierzba, Thomas
    Walker, Richard I.
    VACCINE, 2016, 34 (26) : 2887 - 2894
  • [6] Shigella flexneri infection:: pathogenesis and vaccine development
    Jennison, AV
    Verma, NK
    FEMS MICROBIOLOGY REVIEWS, 2004, 28 (01) : 43 - 58
  • [7] SHIGELLA LIPOPOLYSACCHARIDE - STRUCTURE, GENETICS, AND VACCINE DEVELOPMENT
    BRAHMBHATT, HN
    LINDBERG, AA
    TIMMIS, KN
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1992, 180 : 45 - 64
  • [8] Modern aspects on Shigella pathogenecity and vaccine development - A Review
    Pal, Partha
    INTERNATIONAL LETTERS OF NATURAL SCIENCES, 2014, 17 : 12 - 20
  • [9] Shigella Vaccine Development: Finding the Path of Least Resistance
    Chen, Wilbur H.
    Kotloff, Karen L.
    CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (12) : 904 - 907
  • [10] Progress in HIV vaccine development
    Hsu, Denise C.
    O'Connell, Robert J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (05) : 1018 - 1030